Supernus Pharmaceuticals Inc (SUPN)
28.68
-0.29
(-1.00%)
USD |
NASDAQ |
May 15, 15:39
Supernus Pharmaceuticals Free Cash Flow: 99.84M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.84M |
| December 31, 2023 | 110.53M |
| September 30, 2023 | 93.11M |
| June 30, 2023 | 71.08M |
| March 31, 2023 | 161.81M |
| December 31, 2022 | 116.41M |
| September 30, 2022 | 137.56M |
| June 30, 2022 | 119.72M |
| March 31, 2022 | 94.29M |
| December 31, 2021 | 125.08M |
| September 30, 2021 | 107.98M |
| June 30, 2021 | 117.43M |
| March 31, 2021 | 162.57M |
| December 31, 2020 | 134.71M |
| September 30, 2020 | 146.20M |
| June 30, 2020 | 178.10M |
| March 31, 2020 | 115.35M |
| December 31, 2019 | 141.74M |
| September 30, 2019 | 131.38M |
| June 30, 2019 | 156.44M |
| March 31, 2019 | 134.03M |
| December 31, 2018 | 128.14M |
| September 30, 2018 | 130.97M |
| June 30, 2018 | 107.30M |
| March 31, 2018 | 126.43M |
| Date | Value |
|---|---|
| December 31, 2017 | 112.61M |
| September 30, 2017 | 101.67M |
| June 30, 2017 | 90.92M |
| March 31, 2017 | 81.69M |
| December 31, 2016 | 65.21M |
| September 30, 2016 | 59.64M |
| June 30, 2016 | 33.22M |
| March 31, 2016 | 29.45M |
| December 31, 2015 | 32.42M |
| September 30, 2015 | 19.50M |
| June 30, 2015 | 13.27M |
| March 31, 2015 | -6.175M |
| December 31, 2014 | -25.09M |
| September 30, 2014 | -40.58M |
| June 30, 2014 | -52.00M |
| March 31, 2014 | -61.37M |
| December 31, 2013 | -59.60M |
| September 30, 2013 | -66.59M |
| June 30, 2013 | -62.05M |
| March 31, 2013 | -55.44M |
| December 31, 2012 | -47.95M |
| September 30, 2012 | -40.06M |
| June 30, 2012 | -37.55M |
| March 31, 2012 | -36.97M |
| December 31, 2011 | -36.87M |
Free Cash Flow Range, Past 5 Years
71.08M
Minimum
Jun 2023
178.10M
Maximum
Jun 2020
126.07M
Average
122.40M
Median
Free Cash Flow Benchmarks
| Dynavax Technologies Corp | 52.69M |
| Ligand Pharmaceuticals Inc | -19.62M |
| Pacira BioSciences Inc | 173.19M |
| Esperion Therapeutics Inc | -27.38M |
| Collegium Pharmaceutical Inc | 308.16M |